Wave Life Sciences, Inc. (WVE)

NASDAQ: WVE · Real-Time Price · USD

5.04

-0.12 (-2.33%)

At close: Aug 28, 2026, 4:00 PM EDT

5.09

+0.05 (1.07%)

After-hours: Aug 28, 2026, 7:59 PM EDT

Wave Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	65.37	42.73	108.3	113.31	3.65	40.96
Revenue Growth	-30.42%	-60.55%	-4.42%	3005.10%	-91.09%	104.03%
Cost of Revenue	197.42	182.78	159.68	130.01	115.86	121.88
Gross Profit	-132.05	-140.05	-51.38	-16.7	-112.21	-80.91
Selling, General & Admin	85.87	75.33	59.02	51.29	50.51	46.11
Operating Expenses	85.87	75.33	59.02	51.29	50.51	46.11
Operating Income	-217.92	-215.38	-110.4	-68	-162.72	-127.02
Interest & Investment Income	15.24	10.48	10.16	7.93	1.57	0.03
Other Non Operating Income (Expenses)	0.2	0.53	3.23	1.88	0.01	4.54
Pretax Income	-202.47	-204.38	-97.01	-58.19	-161.14	-122.45
Income Tax Expense	-	-	-	-0.68	0.68	-0.2
Net Income	-202.47	-204.38	-97.01	-57.51	-161.82	-122.25
Net Income to Common	-202.47	-204.38	-97.01	-57.51	-161.82	-122.25
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	188	169	138	106	79	52
Shares Outstanding (Diluted)	188	169	138	106	79	52
Shares Change	21.17%	21.96%	30.33%	34.55%	52.16%	32.12%
EPS (Basic)	-1.08	-1.21	-0.70	-0.54	-2.05	-2.36
EPS (Diluted)	-1.08	-1.21	-0.70	-0.54	-2.05	-2.36
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-193.15	-188.21	-151.96	-20.55	-129.14	-89.55
Free Cash Flow Per Share	-1.03	-1.12	-1.10	-0.19	-1.64	-1.73
Gross Margin	-202.00%	-	-47.44%	-14.74%	-	-197.52%
Operating Margin	-333.36%	-504.09%	-101.94%	-60.01%	-4459.30%	-310.07%
Profit Margin	-309.73%	-478.34%	-89.57%	-50.76%	-4434.72%	-298.42%
Free Cash Flow Margin	-295.46%	-440.50%	-140.31%	-18.13%	-3539.11%	-218.61%
EBITDA	-214.52	-211.94	-106.51	-63	-156.15	-119.53
EBITDA Margin	-	-	-98.34%	-55.60%	-	-291.80%
D&A For EBITDA	3.4	3.44	3.9	5	6.57	7.48
EBIT	-217.92	-215.38	-110.4	-68	-162.72	-127.02
EBIT Margin	-	-	-101.94%	-60.01%	-	-

SEC Filings: 10-K · 10-Q